The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khamzaeva M.S.-U.

Maykop State Technological University

Filonova K.E.

Ural State Medical University

Gorina N.A.

I.I. Mechnikov North-Western State Medical University

Oorzhak Ch.O.

Altai State Medical University

Ivanova V.V.

I.N. Ulyanov Chuvash State University

Analysis of the different approaches effectiveness to the treatment of patients with obesity

Authors:

Khamzaeva M.S.-U., Filonova K.E., Gorina N.A., Oorzhak Ch.O., Ivanova V.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(6): 120‑125

Read: 854 times


To cite this article:

Khamzaeva MS-U, Filonova KE, Gorina NA, Oorzhak ChO, Ivanova VV. Analysis of the different approaches effectiveness to the treatment of patients with obesity. Russian Journal of Preventive Medicine. 2025;28(6):120‑125. (In Russ.)
https://doi.org/10.17116/profmed202528061120

Recommended articles:
The effect of a gami­fication on healthy indi­viduals’ motor acti­vity. Russian Journal of Preventive Medi­cine. 2025;(4):111-116
Dietary restrictions as a risk factor for binge eating diso­rder. Russian Journal of Preventive Medi­cine. 2025;(4):123-129

References:

  1. Dedov II, Mokrysheva NG, Melnichenko GA, et al. Obesity. Consilium Medicum. 2021;23(4):311-325. (In Russ.).
  2. World Health Organization (WHO). Obesity and overweight. UpToDate. 2025. Accessed January 24, 2025. https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight
  3. Federal State Statistics Service (Rosstat). Health statistics report. UpToDate. 2025. Accessed January 24, 2025. https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf
  4. Verbovoy AF, Verbovaya NI, Dolgikh YuA. Obesity as a basis for metabolic syndrome. Ozhirenie i Metabolizm. 2021;18(2):142-149. (In Russ.). https://doi.org/10.14341/omet12707
  5. Obesity: Problems and Solutions. Opportunities for Drug Therapy. Consilium Medicum. 2021;23(7):594-596. (In Russ.).
  6. Livzan MA, Lyalyukova EA, Druk IV, et al. Obesity: Current state of the problem, interdisciplinary approach. Eksperimental’naya i klinicheskaya gastroenterologiya. 2023;(10):5-47. (In Russ.). https://doi.org/10.31146/1682-8658-ecg-218-10-5-47
  7. Parmar RM, Can AS. Dietary approaches to obesity treatment. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2025.
  8. Huang J, Li Y, Chen M, Cai Z, et al. Comparing caloric restriction regimens for effective weight management in adults: a systematic review and network meta-analysis. International Journal of Behavioral Nutrition and Physical Activity. 2024;21:108.  https://doi.org/10.1186/s12966-024-01657-9
  9. Cai L, Yin J, Ma X, et al. Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial. Frontiers in Medicine. 2021;15(3):460-471.  https://doi.org/10.1007/s11684-021-0861-6
  10. Brzuszkiewicz K, Rudziński G, Pożarowska K, et al. Diet and physical activity in the treatment of obesity — current knowledge. Journal of Education, Health and Sport. 2022;12:180-186.  https://doi.org/10.12775/JEHS.2022.12.12.028
  11. Oppert JM, Ciangura C, Bellicha A. Health-enhancing physical activity in obesity management: the need to (seriously) go beyond weight loss. International Journal of Obesity. 2025;49(2):211-213.  https://doi.org/10.1038/s41366-024-01632-1
  12. Pojednic R, D’Arpino E, Halliday I, et al. The Benefits of Physical Activity for People with Obesity, Independent of Weight Loss: A Systematic Review. International Journal of Environmental Research and Public Health. 2022; 19(9):4981. https://doi.org/10.3390/ijerph19094981
  13. Chakhtoura M, Haber R, Ghezzawi M, et al. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. eClinicalMedicine. 2023;58:101882. https://doi.org/10.1016/j.eclinm.2023.101882
  14. Pharmacologic treatment of overweight and obesity in adults. UpToDate. 2025. Accessed January 24, 2025.
  15. Onakpoya IJ, Lee JJ, Mahtani KR, et al. Naltrexone-bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports. British Journal of Clinical Pharmacology. 2020; 86(4):646-667.  https://doi.org/10.1111/bcp.14210
  16. Kelly AS, Bensignor MO, Hsia DS, et al. Phentermine/Topiramate for the treatment of adolescent obesity. NEJM Evidence. 2022;1(6):10.1056/evidoa2200014. https://doi.org/10.1056/evidoa2200014
  17. Chao AM, Tronieri JS, Amaro A, et al. Semaglutide for the treatment of obesity. Trends in Cardiovascular Medicine. 2023;33(3):159-166.  https://doi.org/10.1016/j.tcm.2021.12.008
  18. Bergmann NC, Davies MJ, Lingvay I, et al. Semaglutide for the treatment of overweight and obesity: A review. Diabetes, Obesity and Metabolism. 2023;25(1):18-35.  https://doi.org/10.1111/dom.14863
  19. Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38-48.  https://doi.org/10.1001/jama.2023.24945
  20. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine. 2022;387(3): 205-216.  https://doi.org/10.1056/NEJMoa2206038
  21. Dandgey S, Patten E. Psychological considerations for the holistic management of obesity. Clinical Medicine. 2023;23(4):318-322.  https://doi.org/10.7861/clinmed.2023-0146

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.